MX2009011540A - Tratamiento de desordenes de movimiento con el uso combinado de toxina botulinica y estimulacion del musculo. - Google Patents

Tratamiento de desordenes de movimiento con el uso combinado de toxina botulinica y estimulacion del musculo.

Info

Publication number
MX2009011540A
MX2009011540A MX2009011540A MX2009011540A MX2009011540A MX 2009011540 A MX2009011540 A MX 2009011540A MX 2009011540 A MX2009011540 A MX 2009011540A MX 2009011540 A MX2009011540 A MX 2009011540A MX 2009011540 A MX2009011540 A MX 2009011540A
Authority
MX
Mexico
Prior art keywords
treatment
movement
therapy
muscle stimulation
movement disorders
Prior art date
Application number
MX2009011540A
Other languages
English (en)
Inventor
Susanne Grafe
Florian Heinen
Steffen Berweck
Ingo Borggraefe
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of MX2009011540A publication Critical patent/MX2009011540A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H1/00—Apparatus for passive exercising; Vibrating apparatus; Chiropractic devices, e.g. body impacting devices, external devices for briefly extending or aligning unbroken bones
    • A61H1/02—Stretching or bending or torsioning apparatus for exercising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36067—Movement disorders, e.g. tremor or Parkinson disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Treatment Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Percussion Or Vibration Massage (AREA)

Abstract

La presente invención se relaciona con un método de tratamiento de un desorden de movimiento en un paciente, el método comprende administrar un medicamento que contiene una cantidad efectiva de un agente quimiodesnervante al paciente, donde el paciente es sometido a una terapia de estimulación del músculo, por ejemplo una terapia de movimiento o una terapia de activación del músculo, el medicamento es administrado antes y/o durante y/o después de la terapia de movimiento y un equipo para el tratamiento de pacientes que sufren de desordenes de movimiento, comprendiendo un medicamento que contiene una cantidad efectiva de un agente quimiodesnervante, y un dispositivo para llevar a cabo una terapia de movimiento automatizada.
MX2009011540A 2007-04-26 2008-04-25 Tratamiento de desordenes de movimiento con el uso combinado de toxina botulinica y estimulacion del musculo. MX2009011540A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92630507P 2007-04-26 2007-04-26
EP07008528A EP1985276A1 (en) 2007-04-26 2007-04-26 Treatment of movement disorders by a combined use of a chemodenervating agent and automated movement therapy
PCT/EP2008/003391 WO2008131941A1 (en) 2007-04-26 2008-04-25 Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation

Publications (1)

Publication Number Publication Date
MX2009011540A true MX2009011540A (es) 2010-01-20

Family

ID=38157932

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011540A MX2009011540A (es) 2007-04-26 2008-04-25 Tratamiento de desordenes de movimiento con el uso combinado de toxina botulinica y estimulacion del musculo.

Country Status (7)

Country Link
US (1) US20080279896A1 (es)
EP (2) EP1985276A1 (es)
JP (1) JP2010540409A (es)
CA (1) CA2684529A1 (es)
MX (1) MX2009011540A (es)
RU (1) RU2009143668A (es)
WO (1) WO2008131941A1 (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7598027B2 (en) * 2004-02-24 2009-10-06 Allergan, Inc. Botulinum toxin screening assays
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
EP2246065A1 (en) * 2009-04-29 2010-11-03 Merz Pharma GmbH & Co. KGaA Intrastriatal botulinum toxin therapy
EP2399601A1 (en) * 2010-06-24 2011-12-28 Merz Pharma GmbH & Co. KGaA Botulinum toxin therapy
EP3586908A1 (en) 2011-04-04 2020-01-01 Micron Devices LLC Implantable neural stimulator wireless lead
WO2013027688A1 (ja) * 2011-08-22 2013-02-28 Ryotokuji Kenji 薬剤供給開始時期決定方法及び薬剤搬送システム
CA2848998A1 (en) 2011-09-15 2013-03-21 Stimwave Technologies Incorporated Relay module for implant
US9415218B2 (en) 2011-11-11 2016-08-16 The Regents Of The University Of California Transcutaneous spinal cord stimulation: noninvasive tool for activation of locomotor circuitry
RU2494696C1 (ru) * 2012-04-10 2013-10-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СамГМУ Минздрава России) Способ хирургического лечения сгибательной контрактуры коленного сустава при нормопозиции надколенника у больных детским церебральным параличом
US9278249B2 (en) 2012-07-23 2016-03-08 Icon Health & Fitness, Inc. Exercise cycle with vibration capabilities
US9289648B2 (en) 2012-07-23 2016-03-22 Icon Health & Fitness, Inc. Treadmill with deck vibration
RU2499614C1 (ru) * 2012-09-21 2013-11-27 Федеральное государственное бюджетное учреждение "Саратовский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения Российской Федерации (ФГБУ "СарНИИТО" Минздрава России) Способ электромагнитной стимуляции центральной и периферической нервной системы
US9393453B2 (en) 2012-11-27 2016-07-19 Icon Health & Fitness, Inc. Exercise device with vibration capabilities
US9254393B2 (en) * 2012-12-26 2016-02-09 Micron Devices Llc Wearable antenna assembly
JP6099082B2 (ja) * 2012-12-27 2017-03-22 国立大学法人 筑波大学 訓練システム
US9254409B2 (en) 2013-03-14 2016-02-09 Icon Health & Fitness, Inc. Strength training apparatus with flywheel and related methods
CA2906779C (en) 2013-03-15 2022-08-30 The Regents Of The University Of California Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion
JP6188465B2 (ja) * 2013-07-17 2017-08-30 塩野義製薬株式会社 筋緊張亢進改善薬
EP3046470B1 (en) 2013-09-20 2022-02-23 MDDT Inc. Diagnosing and treating movement disorders
AU2014324660A1 (en) 2013-09-27 2016-04-21 The Regents Of The University Of California Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects
EP3974036A1 (en) 2013-12-26 2022-03-30 iFIT Inc. Magnetic resistance mechanism in a cable machine
US10433612B2 (en) 2014-03-10 2019-10-08 Icon Health & Fitness, Inc. Pressure sensor to quantify work
WO2015191445A1 (en) 2014-06-09 2015-12-17 Icon Health & Fitness, Inc. Cable system incorporated into a treadmill
US10751533B2 (en) 2014-08-21 2020-08-25 The Regents Of The University Of California Regulation of autonomic control of bladder voiding after a complete spinal cord injury
AU2015308779B2 (en) 2014-08-27 2020-06-25 The Regents Of The University Of California Multi-electrode array for spinal cord epidural stimulation
US10258828B2 (en) 2015-01-16 2019-04-16 Icon Health & Fitness, Inc. Controls for an exercise device
JP6930969B2 (ja) 2015-07-08 2021-09-01 ギルローズ ファーマシューティカルズ，リミティド ライアビリティ カンパニー 前頭前皮質プロセシング疾患、歩行及び四肢障害の治療
US10537764B2 (en) 2015-08-07 2020-01-21 Icon Health & Fitness, Inc. Emergency stop with magnetic brake for an exercise device
TWI644702B (zh) 2015-08-26 2018-12-21 美商愛康運動與健康公司 力量運動機械裝置
US10953305B2 (en) 2015-08-26 2021-03-23 Icon Health & Fitness, Inc. Strength exercise mechanisms
US11298533B2 (en) 2015-08-26 2022-04-12 The Regents Of The University Of California Concerted use of noninvasive neuromodulation device with exoskeleton to enable voluntary movement and greater muscle activation when stepping in a chronically paralyzed subject
US10940360B2 (en) 2015-08-26 2021-03-09 Icon Health & Fitness, Inc. Strength exercise mechanisms
US11097122B2 (en) 2015-11-04 2021-08-24 The Regents Of The University Of California Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel
US10561894B2 (en) 2016-03-18 2020-02-18 Icon Health & Fitness, Inc. Treadmill with removable supports
US10272317B2 (en) 2016-03-18 2019-04-30 Icon Health & Fitness, Inc. Lighted pace feature in a treadmill
US10293211B2 (en) 2016-03-18 2019-05-21 Icon Health & Fitness, Inc. Coordinated weight selection
US10493349B2 (en) 2016-03-18 2019-12-03 Icon Health & Fitness, Inc. Display on exercise device
US10441840B2 (en) 2016-03-18 2019-10-15 Icon Health & Fitness, Inc. Collapsible strength exercise machine
US10625137B2 (en) 2016-03-18 2020-04-21 Icon Health & Fitness, Inc. Coordinated displays in an exercise device
CA3018018A1 (en) * 2016-03-25 2017-09-28 Ipsen Biopharm Limited Collecting physical therapy information to enhance treatment efficacy of botulinum toxin
US10252109B2 (en) 2016-05-13 2019-04-09 Icon Health & Fitness, Inc. Weight platform treadmill
RU2614890C1 (ru) * 2016-05-26 2017-03-30 Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России) Способ реабилитации пациентов после травм и поражений поясничного отдела позвоночника
US10471299B2 (en) 2016-07-01 2019-11-12 Icon Health & Fitness, Inc. Systems and methods for cooling internal exercise equipment components
US10441844B2 (en) 2016-07-01 2019-10-15 Icon Health & Fitness, Inc. Cooling systems and methods for exercise equipment
JP7217700B2 (ja) 2016-09-13 2023-02-03 アラーガン、インコーポレイテッド 安定化非タンパク質クロストリジウム毒素組成物
US10500473B2 (en) 2016-10-10 2019-12-10 Icon Health & Fitness, Inc. Console positioning
US10376736B2 (en) 2016-10-12 2019-08-13 Icon Health & Fitness, Inc. Cooling an exercise device during a dive motor runway condition
US10661114B2 (en) 2016-11-01 2020-05-26 Icon Health & Fitness, Inc. Body weight lift mechanism on treadmill
TWI646997B (zh) 2016-11-01 2019-01-11 美商愛康運動與健康公司 用於控制台定位的距離感測器
US10625114B2 (en) 2016-11-01 2020-04-21 Icon Health & Fitness, Inc. Elliptical and stationary bicycle apparatus including row functionality
TWI637770B (zh) 2016-11-01 2018-10-11 美商愛康運動與健康公司 用於固定式腳踏車的落入式樞軸配置
TWI680782B (zh) 2016-12-05 2020-01-01 美商愛康運動與健康公司 於操作期間抵銷跑步機的平台之重量
US10702736B2 (en) 2017-01-14 2020-07-07 Icon Health & Fitness, Inc. Exercise cycle
EP3421081B1 (en) 2017-06-30 2020-04-15 GTX medical B.V. A system for neuromodulation
US20190030118A1 (en) * 2017-07-27 2019-01-31 Ipsen Biopharm Limited Treatment of lower limb spasticity
US11451108B2 (en) 2017-08-16 2022-09-20 Ifit Inc. Systems and methods for axial impact resistance in electric motors
US11992684B2 (en) 2017-12-05 2024-05-28 Ecole Polytechnique Federale De Lausanne (Epfl) System for planning and/or providing neuromodulation
US10729965B2 (en) 2017-12-22 2020-08-04 Icon Health & Fitness, Inc. Audible belt guide in a treadmill
EP3695878B1 (en) 2019-02-12 2023-04-19 ONWARD Medical N.V. A system for neuromodulation
CN109847050B (zh) * 2019-04-17 2021-08-20 上海市中医医院 一种经络艾灸法和中药组合物
EP4228738A1 (en) * 2020-11-16 2023-08-23 MED-EL Elektromedizinische Geräte GmbH System for treating cervical dystonia
CN113332600B (zh) * 2021-06-23 2024-01-09 中山大学 改善帕金森病患者口部表达技巧的治疗仪

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631861A (en) * 1990-02-02 1997-05-20 Virtual Technologies, Inc. Force feedback and texture simulating interface device
US5183462A (en) * 1990-08-21 1993-02-02 Associated Synapse Biologics Controlled administration of chemodenervating pharmaceuticals
US5401243A (en) * 1990-08-21 1995-03-28 Associated Synapse Biologics Controlled administration of chemodenervating pharmaceuticals
US7384918B2 (en) * 1991-09-24 2008-06-10 Allergan, Inc. Botulinum toxin for treating muscle contracture
US6057373A (en) * 1997-05-22 2000-05-02 Synchroneuron, Llc Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
DE59906800D1 (de) * 1998-11-13 2003-10-02 Hocoma Ag Staefa Vorrichtung und verfahren zur automatisierung der laufbandtherapie
EP1169003B1 (de) * 1999-04-07 2004-03-31 Balgrist/Schweiz. Paraplegikerzentrum Vorrichtung und verfahren für eine lokomotionstherapie
AR061669A1 (es) * 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica

Also Published As

Publication number Publication date
US20080279896A1 (en) 2008-11-13
JP2010540409A (ja) 2010-12-24
WO2008131941A1 (en) 2008-11-06
EP1985276A1 (en) 2008-10-29
EP2148641A1 (en) 2010-02-03
CA2684529A1 (en) 2008-11-06
RU2009143668A (ru) 2011-06-10

Similar Documents

Publication Publication Date Title
MX2009011540A (es) Tratamiento de desordenes de movimiento con el uso combinado de toxina botulinica y estimulacion del musculo.
MX2010012860A (es) Metodos para tratar cancer del sistema nervioso central.
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
WO2008039898A3 (en) Methods for the treatment of a traumatic central nervous system injury
MX336710B (es) Oligoribonucleotidos y metodos de uso de los mismos para tratamiento de la alopecia, insuficiencia renal aguda y otras enfermedades.
WO2010002936A3 (en) Systems, methods and devices for paired plasticity
IL171607A (en) Use of botulinum toxin for the treatment of sinusitis-induced headaches
EA201491460A1 (ru) ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα
NZ591362A (en) Multiple-variable dose regimen for treating tnfa-related disorders
NZ603717A (en) Suture line administration technique using botulinum toxins
SI1913947T1 (sl) Kombinirana terapija za zdravljenje raka
DE602005019367D1 (de) Verbesserte Zelltherapie und Gewebsregeneration mittels Stosswellen bei Patienten mit kardiovaskulären and neurologischen Krankheiten
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
MX2022005303A (es) Agentes y usos de los mismos para prevenir y/o tratar enfermedades neurologicas.
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
WO2006002096A3 (en) Low doses of l-citrulline for treating diseases
MX2008013635A (es) Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
MX2020001768A (es) Metodos de tratamiento de la osteoartritis con gel de canabidiol transdermico.
IN2014CN03333A (es)
EP3590338A3 (en) Medical treatments based on anamorelin
TW200724158A (en) Combination therapy in the treatment of cancer
MX2019010732A (es) Uso de moduladores de receptor de glucocorticoide en el tratamiento de tumores secretores de catecolamina.
MX2010006724A (es) Regimenes terapeuticos para el tratamiento de desordenes inmunoinflamatorios.
WO2009131850A3 (en) Pai-1 expression and activity inhibitors for the treatment of ocular disorders

Legal Events

Date Code Title Description
FA Abandonment or withdrawal